BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12792160)

  • 1. Impact of pneumococcal vaccination on morbidity and mortality of geriatric patients: a case-controlled study.
    Wagner C; Popp W; Posch M; Vlasich C; Rosenberger-Spitzy A
    Gerontology; 2003; 49(4):246-50. PubMed ID: 12792160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
    Baldo V; Cocchio S; Gallo T; Furlan P; Romor P; Bertoncello C; Buja A; Baldovin T
    PLoS One; 2016; 11(11):e0166637. PubMed ID: 27846277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.
    Tsai YH; Hsieh MJ; Chang CJ; Wen YW; Hu HC; Chao YN; Huang YC; Yang CT; Huang CC
    Vaccine; 2015 Jun; 33(25):2897-902. PubMed ID: 25936662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
    Ingels HA
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study.
    Kondo K; Suzuki K; Washio M; Ohfuji S; Fukushima W; Maeda A; Hirota Y;
    Vaccine; 2017 Aug; 35(36):4806-4810. PubMed ID: 28818473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia.
    Fisman DN; Abrutyn E; Spaude KA; Kim A; Kirchner C; Daley J
    Clin Infect Dis; 2006 Apr; 42(8):1093-101. PubMed ID: 16575726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
    Hedlund J
    Scand J Infect Dis Suppl; 1995; 97():1-60. PubMed ID: 8584866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines to Prevent Pneumococcal Community-Acquired Pneumonia.
    van Werkhoven CH; Huijts SM
    Clin Chest Med; 2018 Dec; 39(4):733-752. PubMed ID: 30390745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of pneumococcal polysaccharide vaccine in older adults.
    Jackson LA; Neuzil KM; Yu O; Benson P; Barlow WE; Adams AL; Hanson CA; Mahoney LD; Shay DK; Thompson WW;
    N Engl J Med; 2003 May; 348(18):1747-55. PubMed ID: 12724480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive disease and hospital-treated pneumonia among people aged ≥65 years: a retrospective case-control study.
    Leventer-Roberts M; Feldman BS; Brufman I; Cohen-Stavi CJ; Hoshen M; Balicer RD
    Clin Infect Dis; 2015 May; 60(10):1472-80. PubMed ID: 25669354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older.
    Vila-Corcoles A; Ochoa-Gondar O; Guzmán JA; Rodriguez-Blanco T; Salsench E; Fuentes CM;
    BMC Infect Dis; 2010 Mar; 10():73. PubMed ID: 20298596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons.
    Christenson B; Hedlund J; Lundbergh P; Ortqvist A
    Eur Respir J; 2004 Mar; 23(3):363-8. PubMed ID: 15065822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting.
    Mangtani P; Roberts JA; Hall AJ; Cutts FT
    Int J Epidemiol; 2005 Jun; 34(3):565-74. PubMed ID: 15764694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recommendations for prevention of community-acquired pneumonia with bacteremia as the leading form of invasive pneumococcal infections in the population of people over 50 years of age and risk groups above 19 years of age].
    Albrecht P; Antczak A; Hryniewicz W; Skoczyńska A; Radzikowski A; Kedziora-Kornatowska K; Bernatowska E; Stompór T; Grodzicki T; Gyrczuk E; Imiela J; Jedrzejczak W; Windak A
    Pol Merkur Lekarski; 2014 Feb; 36(212):79-87. PubMed ID: 24720101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe.
    Fedson DS; Nicolas-Spony L; Klemets P; van der Linden M; Marques A; Salleras L; Samson SI
    Expert Rev Vaccines; 2011 Aug; 10(8):1143-67. PubMed ID: 21810065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study.
    Wiemken TL; Carrico RM; Klein SL; Jonsson CB; Peyrani P; Kelley RR; Aliberti S; Blasi F; Fernandez-Gonzalez R; Lopardo G; Ramirez JA;
    Vaccine; 2014 Apr; 32(19):2198-203. PubMed ID: 24613522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of mortality and pneumonia among nursing home older adults by dual pneumococcal and seasonal influenza vaccination during a pandemic caused by novel pandemic influenza A (H1N1).
    Chan TC; Hung IF; Luk JK; Shea YF; Chan FH; Woo PC; Chu LW
    J Am Med Dir Assoc; 2012 Oct; 13(8):698-703. PubMed ID: 22722051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Education does pay off: pneumococcal vaccine screening and administration in hospitalized adult patients with pneumonia.
    Kruspe R; Lillis R; Daberkow DW; Blais CM; Wilbright W; Gupta S; Gould CA; Sun T; Martinez JA; deBoisblanc B; Ladabaum U; Sanders CV; Lopez FA
    J La State Med Soc; 2003; 155(6):325-31. PubMed ID: 14750752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
    Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
    Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease.
    Nichol KL; Baken L; Wuorenma J; Nelson A
    Arch Intern Med; 1999 Nov; 159(20):2437-42. PubMed ID: 10665892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.